ENLIVEN THERAPEUTICS, INC. (ELVN) /
The debt of ENLIVEN THERAPEUTICS, INC. over the past 7 years
Chart ENLIVEN THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, ENLIVEN THERAPEUTICS, INC. had liquid cash of $462.62M and total debt of $0: net cash of $462.62M. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $462.62M* | $0 | $462.62M |
| 2024ended Dec 31, 2024 | $313.44M* | $0 | $313.44M |
| 2023ended Dec 31, 2023 | $253.15M* | $0 | $253.15M |
| 2022ended Dec 31, 2022 | $75.54M* | $0 | $75.54M |
| 2021ended Dec 31, 2021 | $90.28M* | $0 | $90.28M |
| 2020ended Dec 31, 2020 | $88.22M* | $0 | $88.22M |
| 2019ended Dec 31, 2019 | $28.91M* | $0 | $28.91M |
Fiscal years as ENLIVEN THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ENLIVEN THERAPEUTICS, INC.
- The profitability of ENLIVEN THERAPEUTICS, INC.
- The cash flow of ENLIVEN THERAPEUTICS, INC.
- All of ENLIVEN THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- NBTBNBT BANCORP INC
- LGNLegence Corp.
- REZIResideo Technologies, Inc.
- BCCBoise Cascade Company
- HWKNHAWKINS, INC.
Not investment advice. This page shows what ENLIVEN THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.